• Home
  • Our Future Pipeline

Our Future Pipeline

We pioneer dermatology by driving science to discover and develop new innovative solutions within medical dermatology.

We have more than a 100-year of experience with drug development and discovery

We have R&D specialists positioned around the globe to discover and develop innovative solutions within medical dermatology to people living with a skin disease

 

Research and Development

At LEO Pharma Research & Development (R&D), we pioneer dermatology by driving science to discover and develop new innovative solutions for the treatment of psoriasis, atopic dermatitis and rare diseases as one of the world’s leading companies within medical dermatology.

 

Our innovative ecosystem

We believe that being truly innovative requires global ambitions, significant investments and a diverse approach where multiple initiatives go hand in hand. Collaboration and co-creation are the glue that binds our ecosystem together, advancing science and technology to fuel the development of new treatment solutions.

Read more

 

As one of the world’s leading companies within medical dermatology, we push the limits to understand patients, skin and dermatological diseases. We would like to pave the way towards precision medicine, prevention and eventually curing skin diseases.

 

LEO Pharma invests heavily in R&D and 18% of our turnover is allocated to research and development of new innovative solutions.

 

Our research organization is situated at our headquarters in Ballerup, Denmark closely collaborating with industry partners around the world as well as with our development organization and our Science & Tech Hubs in Boston, US and Tokyo, Japan.

 

Our global development organization is situated in Madison, US and Ballerup Denmark respectively.

 

We drive our research and development projects in multi-disciplinary and cross-functional project teams integrating advanced knowledge in R&D disciplines with expertise in clinical practices and therapeutic needs.